[PDF][PDF] mTOR drives its own activation via SCFβTrCP-dependent degradation of the mTOR inhibitor DEPTOR

D Gao, H Inuzuka, MKM Tan, H Fukushima… - Molecular cell, 2011 - cell.com
D Gao, H Inuzuka, MKM Tan, H Fukushima, JW Locasale, P Liu, L Wan, B Zhai, YR Chin
Molecular cell, 2011cell.com
The activities of both mTORC1 and mTORC2 are negatively regulated by their endogenous
inhibitor, DEPTOR. As such, the abundance of DEPTOR is a critical determinant in the
activity status of the mTOR network. DEPTOR stability is governed by the 26S-proteasome
through a largely unknown mechanism. Here we describe an mTOR-dependent
phosphorylation-driven pathway for DEPTOR destruction via SCF βTrCP. DEPTOR
phosphorylation by mTOR in response to growth signals, and in collaboration with casein …
Summary
The activities of both mTORC1 and mTORC2 are negatively regulated by their endogenous inhibitor, DEPTOR. As such, the abundance of DEPTOR is a critical determinant in the activity status of the mTOR network. DEPTOR stability is governed by the 26S-proteasome through a largely unknown mechanism. Here we describe an mTOR-dependent phosphorylation-driven pathway for DEPTOR destruction via SCFβTrCP. DEPTOR phosphorylation by mTOR in response to growth signals, and in collaboration with casein kinase I (CKI), generates a phosphodegron that binds βTrCP. Failure to degrade DEPTOR through either degron mutation or βTrCP depletion leads to reduced mTOR activity, reduced S6 kinase activity, and activation of autophagy to reduce cell growth. This work expands the current understanding of mTOR regulation by revealing a positive feedback loop involving mTOR and CKI-dependent turnover of its inhibitor, DEPTOR, suggesting that misregulation of the DEPTOR destruction pathway might contribute to aberrant activation of mTOR in disease.
cell.com